Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022)
Kiniksa Pharmaceuticals International (KNSA) reported Receivables - Other of $7.7 million for Q4 2022.
Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022) Analysis & Trends
Kiniksa Pharmaceuticals International has reported Receivables - Other for 1 years, with the latest figure at $7.7 million in Q4 2022.
- For the quarter ending Q4 2022, Receivables - Other changed N/A year-over-year to $7.7 million; the trailing twelve-month figure through Dec 2022 stood at $7.7 million (changed N/A YoY), and the FY2022 full-year result was $7.7 million, changed N/A from the prior year.
- Receivables - Other for Q4 2022 stood at $7.7 million.
- The five-year high for Receivables - Other was $7.7 million in Q4 2022, with the low at $7.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kiniksa Pharmaceuticals International | 3.73 Bn | 3.26 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.66 Mn |
| Dec 31, 2022 | 7.66 Mn |